A Review of Safety, Efficacy, and Utilization of Erythropoietin, Darbepoetin, and Peginesatide for Patients with Cancer or Chronic Kidney Disease: A Report from the Southern Network on Adverse Reactions (SONAR)

The erythropoiesis-stimulating agents (ESAs) erythropoietin and darbepoetin prevent transfusions among chemotherapy-associated anemia patients. Clinical trials, meta-analyses, and guidelines identify mortality, tumor progression, and venous thromboembolism (VTE) risks with ESA administration in this...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Bennett, Charles L., Spiegel, David M., Macdougall, Iain C., Norris, LeAnn, Qureshi, Zaina P., Sartor, Oliver, Lai, Stephen Y., Tallman, Martin S., Raisch, Dennis W., Smith, Sheila Weiss, Silver, Samuel, Murday, Alanna S., Armitage, James O., Goldsmith, David
Formato: Artigo
Idioma:Inglês
Publicado em: 2012
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3947540/
https://ncbi.nlm.nih.gov/pubmed/23111861
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1055/s-0032-1328884
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados